Markers of D(2) and D(3) receptor activity in vivo: PET scan and prolactin

Thérapie
Nitza Thomasson-PerretElisabeth Mocaër

Abstract

Positrons Emission Tomography (PET) allows to evaluate the dopaminergic activity of antipsychotic, by measuring post synaptic D(2) dopaminergic receptors occupancy. A good correlation was brought forward between a rate of occupancy of 80% of striatal D(2) receptors and the occurrence of extrapyramidal effects. These PET studies have also established that at least 60% D(2) receptors occupancy was predictive of clinical antipsychotic response. The PET studies in healthy volunteers can then be used to help choose doses to be tested during the clinical trials of new antipsychotic drugs. The increase in prolactin level is one other of the markers of the antagonist dopaminergic activity which concerns D(2) receptors of the pituitary gland. The example of S 33138, a potential antipsychotic, preferential D(3) versus D(2) receptor antagonist will be given to illustrate these data. The results of two PET studies as well as the effects on prolactin and extrapyramidal signs will be presented.

References

May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T R Barnes
Feb 1, 1987·Biology of Reproduction·K E Moore
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Jan 1, 1981·Psychopharmacology·J M KaneS Bailine
Sep 22, 2001·Neuroscience and Biobehavioral Reviews·N M RichtandS M Strakowski
Jan 5, 2002·The American Journal of Psychiatry·Peter TurroneAlastair J Flint
Dec 7, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Peter S Talbot, Marc Laruelle
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shitij Kapur, David Mamo
Dec 22, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Iluminada CorripioEnric Alvarez
Mar 1, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Joseph M Pierre
Jun 7, 2005·Expert Opinion on Pharmacotherapy·Hans-Jürgen Möller
Jul 5, 2005·Drug Discovery Today·Jeffrey N Joyce, Mark J Millan

❮ Previous
Next ❯

Citations

Jul 29, 2010·The International Journal of Neuropsychopharmacology·Mark J MillanJay S Schneider

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here